August 18, 2022

The FDA has approved Akorn’s generic version of Merck’s Cetrotide® (cetrorelix acetate for injection) 0.25mg to prevent premature ovulation during controlled ovarian stimulation.

  • Cetrotide first received FDA approval in Akorn’s 0.25mg strength generic is the first generic version of the drug.
  • Recommended dosing is 25mg once daily during the early- to mid-follicular phase.
  • Launch and pricing information are not yet available.
August 18, 2022

U.S. FDA Approves First Cetrotide Generic

Read More
August 17, 2022

Zynteglo Approved as Gene Therapy for Rare Blood Disorder

Read More